CL2021000171A1 - Procedimiento y productos intermedios para la preparación de bilastina - Google Patents

Procedimiento y productos intermedios para la preparación de bilastina

Info

Publication number
CL2021000171A1
CL2021000171A1 CL2021000171A CL2021000171A CL2021000171A1 CL 2021000171 A1 CL2021000171 A1 CL 2021000171A1 CL 2021000171 A CL2021000171 A CL 2021000171A CL 2021000171 A CL2021000171 A CL 2021000171A CL 2021000171 A1 CL2021000171 A1 CL 2021000171A1
Authority
CL
Chile
Prior art keywords
bilastine
intermediates
procedure
preparation
iii
Prior art date
Application number
CL2021000171A
Other languages
English (en)
Inventor
Herrero Gonzalo Hernández
García Tania González
Poladura Pablo Morán
Cerdeiras Paloma Tato
Domínguez Neftalí García
González Álvaro Ganza
Original Assignee
Faes Farma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Faes Farma Sa filed Critical Faes Farma Sa
Publication of CL2021000171A1 publication Critical patent/CL2021000171A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/62—Halogen-containing esters
    • C07C69/63—Halogen-containing esters of saturated acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/39—Preparation of carboxylic acid esters by oxidation of groups which are precursors for the acid moiety of the ester
    • C07C67/42—Preparation of carboxylic acid esters by oxidation of groups which are precursors for the acid moiety of the ester by oxidation of secondary alcohols or ketones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C07C45/46—Friedel-Crafts reactions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/09—Preparation of carboxylic acids or their salts, halides or anhydrides from carboxylic acid esters or lactones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La invención se refiere a un procedimiento para preparar un compuesto de (III) X R1O O (III) en la que X es un grupo saliente; y R1 es alquilo C1-C6; que comprende la transposición oxidativa de un compuesto de fórmula (II) o un solvato del mismo X O (II). Los compuestos de fórmula (III) son productos intermedios clave en la síntesis de bilastina.
CL2021000171A 2018-07-24 2021-01-21 Procedimiento y productos intermedios para la preparación de bilastina CL2021000171A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP18382556.1A EP3599235A1 (en) 2018-07-24 2018-07-24 Process and intermediates for the preparation of bilastine

Publications (1)

Publication Number Publication Date
CL2021000171A1 true CL2021000171A1 (es) 2021-07-09

Family

ID=63103892

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2021000171A CL2021000171A1 (es) 2018-07-24 2021-01-21 Procedimiento y productos intermedios para la preparación de bilastina

Country Status (28)

Country Link
US (1) US11370742B2 (es)
EP (2) EP3599235A1 (es)
JP (1) JP7145312B2 (es)
KR (1) KR20210038905A (es)
CN (1) CN112469709A (es)
AU (1) AU2019311251B2 (es)
BR (1) BR112021001179A2 (es)
CA (1) CA3107879A1 (es)
CL (1) CL2021000171A1 (es)
CO (1) CO2021000940A2 (es)
CY (1) CY1124909T1 (es)
EA (1) EA202190346A1 (es)
EC (1) ECSP21008461A (es)
ES (1) ES2901786T3 (es)
HR (1) HRP20211994T1 (es)
HU (1) HUE056822T2 (es)
LT (1) LT3826997T (es)
MA (1) MA53370B1 (es)
MX (1) MX2021000924A (es)
MY (1) MY206164A (es)
PE (1) PE20211243A1 (es)
PH (1) PH12021550144A1 (es)
PL (1) PL3826997T3 (es)
PT (1) PT3826997T (es)
SG (1) SG11202100576WA (es)
SI (1) SI3826997T1 (es)
WO (1) WO2020020873A1 (es)
ZA (1) ZA202101214B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112110893A (zh) * 2020-10-28 2020-12-22 山东齐环医药科技有限公司 一种比拉斯汀的制备方法
WO2022214921A1 (en) * 2021-04-10 2022-10-13 Ocimum Labs Private Limited An improved process for the preparation of intermediates used in the preparation of antihistamine agent
US20250129039A1 (en) * 2021-08-19 2025-04-24 Biophore India Pharmaceuticals Pvt. Ltd. Novel process for the preparation of bilastine and intermediates thereof
WO2024116135A1 (en) * 2022-12-01 2024-06-06 Piramal Pharma Limited Process for the preparation of bilastine
CN117024313B (zh) * 2023-08-09 2024-08-30 重庆恩联生物科技有限公司 一种比拉斯汀中间体2-甲基-2-{4-[2-甲基-4-磺酰氧基-乙基]苯基}丙酸甲酯的合成方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52108943A (en) * 1976-03-10 1977-09-12 Teikoku Hormone Mfg Co Ltd Alkyl phenyl ketone derivative
WO2009050116A2 (en) 2007-10-17 2009-04-23 Basf Se Adhesion promoting photoinitiators for uv cured coatings over metal surfaces
EP2240464A4 (en) 2008-02-12 2011-09-14 Yuhan Corp PROCESS FOR THE PREPARATION OF 2-METHYL-2'-PHENYLPROPIONIC ACID DERIVATIVES AND NOVEL INTERMEDIATE PRODUCTS
CN102675101B (zh) 2012-05-16 2014-01-29 王蕾 2-(4-卤乙基)苯基-2-甲基丙酸酯的制备方法及合成比拉斯汀的方法
CN103159674A (zh) * 2013-04-03 2013-06-19 苏州安诺生物医药技术有限公司 2-苯烷酰胺类化合物及其制备方法、药物组合物和用途
CN104151160A (zh) 2013-05-15 2014-11-19 重庆华邦制药有限公司 用酯类化合物合成2-甲基丙酸酯衍生物的方法
WO2014188453A2 (en) * 2013-05-24 2014-11-27 Msn Laboratories Private Limited Novel process for the preparation of 2-[4-(2-{4-[1-(2-ethoxyethyl)-1h-benzimidazol-2-yl]-1-piperidinyl}ethyl) phenyl]-2-methylpropanoic acid
CN104326909A (zh) 2014-09-22 2015-02-04 暨南大学 一种制备α,α-二甲基-4-(2-卤乙基)苯乙酸酯及合成比拉斯汀的方法

Also Published As

Publication number Publication date
HUE056822T2 (hu) 2022-03-28
SI3826997T1 (sl) 2022-01-31
HRP20211994T1 (hr) 2022-04-01
CO2021000940A2 (es) 2021-02-17
AU2019311251A1 (en) 2021-03-04
MA53370A (fr) 2021-06-02
EP3599235A1 (en) 2020-01-29
JP7145312B2 (ja) 2022-09-30
LT3826997T (lt) 2021-12-27
PL3826997T3 (pl) 2022-05-30
ZA202101214B (en) 2022-09-28
PH12021550144A1 (en) 2021-09-13
MY206164A (en) 2024-12-03
MA53370B1 (fr) 2021-12-31
PT3826997T (pt) 2022-01-21
CY1124909T1 (el) 2023-01-05
JP2021531300A (ja) 2021-11-18
US11370742B2 (en) 2022-06-28
SG11202100576WA (en) 2021-02-25
EP3826997A1 (en) 2021-06-02
CA3107879A1 (en) 2020-01-30
EA202190346A1 (ru) 2021-05-20
ECSP21008461A (es) 2021-03-31
PE20211243A1 (es) 2021-07-13
CN112469709A (zh) 2021-03-09
WO2020020873A1 (en) 2020-01-30
ES2901786T3 (es) 2022-03-23
KR20210038905A (ko) 2021-04-08
EP3826997B1 (en) 2021-11-10
AU2019311251B2 (en) 2021-10-21
BR112021001179A2 (pt) 2021-04-27
US20210300856A1 (en) 2021-09-30
MX2021000924A (es) 2021-03-31

Similar Documents

Publication Publication Date Title
CL2021000171A1 (es) Procedimiento y productos intermedios para la preparación de bilastina
MX390287B (es) Composiciones farmacéuticas que contienen derivados de piridona policíclicos sustituidos y profármacos de los mismos.
AR117101A1 (es) Síntesis mejorada del intermedio clave del compuesto inhibidor de g12c de kras
MX2021005714A (es) Nuevos compuestos heterociclicos.
CL2019002297A1 (es) Inhibidores de mnk sustituidos con piperidina y métodos relacionados con los mismos.
CL2018000952A1 (es) Compuestos útiles como inmunomoduladores
CO2023004195A2 (es) Compuestos heterocíclicos
CY1124450T1 (el) Νουκλεοτιδια βητα-νικοτινικου εστερα και διεργασιες για την παρασκευη αυτων
MX2018005733A (es) Fosforamidita de agrupacion de n-acetilgalactosamina (galnac).
CL2019002919A1 (es) Compuestos inhibidores vmat2 y composiciones relacionadas.
MX2019014054A (es) Profarmacos de glucuronida de inhibidores de la cinasa janus.
CU24274B1 (es) Compuestos intermediarios para la síntesis de treprostinil
AR100049A1 (es) Derivados de dihidrotiazina y dihidrooxazina con actividad inhibidora de bace1
PE20200445A1 (es) Inhibidores pirazolicos de magl
MX2018006390A (es) Composiciones y metodos para tratar accidente cerebrovascular isquemico.
FR3087439B1 (fr) Procédé pour la préparation de 3α-hydroxy-5α-prégnan-20-one (brexanolone)
PE20191103A1 (es) Inhibidores de dopamina-b-hidroxilasa
BR112022012153A2 (pt) Processo para preparar um composto e composto
CY1123038T1 (el) Παρασκευη της 4,5,6,7-τετραϋδροϊσοξαζολο[5,4-c]πυριδιν-3-ολης
CO2022001513A2 (es) Proceso e intermediarios para la preparación de piroxasulfona
PY2242414A (es) Intermedio novedoso para la preparación de piroxasulfona
MX2018014130A (es) Procedimiento e intermedios para la 6,7-alfa-epoxidacion de 4,6-dienos esteroideos.
SA520412408B1 (ar) عملية تحضير مركبات ثنائي أريل أوكسي بنزو ديازول غير متجانسة مزدوجة الاستبدال
AR125039A2 (es) Un compuesto derivado de indeno-amida
MX2021007511A (es) Procedimiento para la preparacion de anilinas sustituidas.